Sheaff Brock Investment Advisors, LLC Alkermes Plc. Transaction History
Sheaff Brock Investment Advisors, LLC
- $1.14 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$657 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$435 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$313 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$268 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.83B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...